Reclassifying medicines from prescription-only to OTC status should be one of the priorities for the UK government as it tries to ensure the nation’s health system is fit for the future, insists consumer healthcare industry association PAGB.
“For over 40 years, the UK has led the way in reclassification,” PAGB notes in its recently published State of the Nation report
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?